Al-Zaid Bashaier, Al-Sabah Suleiman
Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Front Pharmacol. 2025 Mar 25;16:1528295. doi: 10.3389/fphar.2025.1528295. eCollection 2025.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are important regulators of metabolism and mediate the incretin effect. This glucose-dependent potentiation of insulin secretion is severely impaired in patients with type-2 diabetes mellitus. While pharmacological doses of GLP-1 can overcome this impairment, the same is not true for GIP. The reasons for this are unclear. However, differences in the signalling profiles of the GLP-1 and GIP receptors (GLP-1R and GIPR) may contribute. GLP-1R and GIPR are closely related G protein-coupled receptors but differ in their ability to recruit arrestin, GIPR being relatively poorer. Furthermore, these receptors have been reported to utilize different mechanisms to undergo agonist-induced internalization. This study aimed to identify the role of the C-terminal region of the two receptors in their differing signalling behaviour using chimeric receptors where the C-terminal tail of one receptor was replaced with that of the other. Replacement of the C-terminal tail had only limited effects on G protein and arrestin recruitment to either receptor. GIP-stimulated internalisation of GIPR occurred at a significantly ( < 0.001) slower rate than GLP-1-stimulated internalisation of GLP-1R. Replacement of the C-terminal tail of GIPR with that of GLP-1R significantly ( < 0.05) increased the internalization rate but not to the rate of wild-type GLP-1R. The reciprocal substitution significantly ( < 0.005) decreased internalization rate. These data show that the C-terminal region of GLP-1R and GIPR is not the critical determinant of their differing ability to recruit arrestin but modulates receptor endocytosis.
胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素多肽(GIP)是重要的代谢调节因子,并介导肠促胰岛素效应。在2型糖尿病患者中,这种胰岛素分泌的葡萄糖依赖性增强严重受损。虽然药理剂量的GLP-1可以克服这种损伤,但GIP并非如此。其原因尚不清楚。然而,GLP-1和GIP受体(GLP-1R和GIPR)信号转导谱的差异可能起作用。GLP-1R和GIPR是密切相关的G蛋白偶联受体,但在募集抑制蛋白的能力上有所不同,GIPR相对较差。此外,据报道这些受体利用不同的机制进行激动剂诱导的内化。本研究旨在使用嵌合受体来确定这两种受体的C末端区域在其不同信号转导行为中的作用,其中一个受体的C末端尾巴被另一个受体的C末端尾巴所取代。C末端尾巴的替换对任一受体的G蛋白和抑制蛋白募集只有有限的影响。GIP刺激的GIPR内化速率明显(<0.001)慢于GLP-1刺激的GLP-1R内化速率。用GLP-1R的C末端尾巴替换GIPR的C末端尾巴显著(<0.05)提高了内化速率,但未达到野生型GLP-1R的速率。反向替换显著(<0.005)降低了内化速率。这些数据表明,GLP-1R和GIPR的C末端区域不是它们募集抑制蛋白能力不同的关键决定因素,但可调节受体内吞作用。